evidence: An FDA advisory panel endorses the first COVID-19 vaccine. The application for the Pfizer and BioNTech’s vaccine is heard in a public, day-long meeting; voting 17-4, with 1 abstention, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) decides the benefits of the vaccine outweigh the risks for those 16 and older. [...] December 17 — FDA Panel Backs Moderna COVID-19 Vaccine [...] December 18 — FDA Signs Off on EUA for Moderna's COVID-19 Vaccine